A paucity of information exists regarding the presence of local renin—angiotensin systems (RASs) in skeletal muscle and associated muscle stem cells. Skeletal muscle and muscle stem cells were isolated from C57BL/6 mice and examined for the presence of a local RAS using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR), immunohistochemistry (IHC), Western blotting and liquid chromatography-mass spectrometry (LC-MS). Furthermore, the effect of mechanical stimulation on RAS member gene expression was analysed. Whole skeletal muscle, primary myoblasts and C2C12 derived myoblasts and myotubes differentially expressed members of the RAS including angiotensinogen, angiotensin-converting enzyme (ACE), angiotensin II (Ang II) type 1 (AT1) and type 2 (AT2). Renin transcripts were never detected, however, mRNA for the ‘renin-like’ enzyme cathepsin D was observed and Ang I and Ang II were identified in cell culture supernatants from proliferating myoblasts. AT1 appeared to co-localise with polymerised actin filaments in proliferating myoblasts and was primarily found in the nucleus of terminally differentiated myotubes. Furthermore, mechanical stretch of proliferating and differentiating C2C12 cells differentially induced mRNA expression of angiotensinogen, AT 1 and AT2. Proliferating and differentiated muscle stem cells possess a local stress-responsive RAS in vitro. The precise function of a local RAS in myoblasts remains unknown. However, evidence presented here suggests that Ang II may be a regulator of skeletal muscle myoblasts.
Lavoie JL and Sigmund CDMinireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology2003; 144: 2179-2183.
2.
Paul M., Poyan Mehr A. and Kreutz R.Physiology of local renin-angiotensin systems. Physiol Rev2006; 86: 747-803.
3.
Danser AH, Saris JJ, Schuijt MP and van Kats JPIs there a local renin-angiotensin system in the heart?Cardiovasc Res1999; 44: 252-265.
4.
Baker KM, Chernin MI, Wixson SK and Aceto JFRenin- angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol1990; 259(2Pt2): H324- H332.
5.
Becker BN, Yasuda T., Kondo S., Vaikunth S., Homma T. and Harris RCMechanical stretch/relaxation stimulates a cellular renin-angiotensin system in cultured rat mesangial cells. Exp Nephrol1998; 6: 57-66.
6.
Gordon SE, Davis BS, Carlson CJ and Booth FWANG II is required for optimal overload-induced skeletal muscle hypertrophy . Am J Physiol Endocrinol Metab2001; 280: E150-E159.
7.
Westerkamp CM and Gordon SEAngiotensin-converting enzyme inhibition attenuates myonuclear addition in overloaded slow-twitch skeletal muscle. Am J Physiol Regul Integr Comp Physiol2005; 289: R1223-R1231.
8.
Reneland R. and Lithell H.Angiotensin-converting enzyme in human skeletal muscle. A simple in vitro assay of activity in needle biopsy specimens. Scand J Clin Lab Invest1994; 54: 105-111.
9.
Ward PE, Russell JS and Vaghy PLAngiotensin and bradykinin metabolism by peptidases identified in skeletal muscle. Peptides1995; 16: 1073-1078.
10.
Danser AH, Koning MM, Admiraal PJ, et al. Production of angiotensins I and II at tissue sites in intact pigs. Am J Physiol1992; 263(2Pt2): H429-H437.
11.
Ohishi M., Ueda M., Rakugi H., et al. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans. Circulation1997; 96: 3328-3337.
12.
Rando TA and Blau HMPrimary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol1994; 125: 1275-1287.
13.
Livak KJ and Schmittgen TDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods2001; 25: 402-408.
14.
Tatsumi R., Sheehan SM, Iwasaki H., Hattori A. and Allen REMechanical stretch induces activation of skeletal muscle satellite cells in vitro. Exp Cell Res2001; 267: 107-114.
15.
Genest J., Cantin M., Garcia R., et al. Extrarenal angiotensin-forming enzymes. Clin Exp Hypertens A1983; 5: 1065-1080.
16.
Malhotra R. , Sadoshima J., Brosius FC, 3rd and Izumo S.Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes in vitro. Circ Res1999; 85: 137-146.
17.
Qi JS, Minor LK, Smith C., et al. Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: comparison with angiotensin II receptors. Peptides2005; 26: 683-690.
18.
Mori S. and Tokuyama K.ACE activity affects myogenic differentiation via mTOR signaling. Biochem Biophys Res Commun2007; 363: 597-602.
19.
Lavrentyev EN, Estes AM and Malik KUMechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells. Circ Res2007; 101: 455-464.
20.
Karlsson C. , Lindell K., Ottosson M., Sjöström L., Carlsson B. and Carlsson LMHuman adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab1998 ; 83: 3925-3929.
21.
Billet S., Aguilar F., Baudry C. and Clauser E.Role of angiotensin II AT1 receptor activation in cardiovascular diseases . Kidney Int2008; 74: 1379-1384.
22.
Zhu YC, Zhu YZ, Lu N., Wang MJ, Wang YX and Yao T.Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling. Clin Exp Pharmacol Physiol2003 ; 30: 911-918.
23.
Bkaily G., Sleiman S., Stephan J., et al. Angiotensin II AT1 receptor internalization, translocation and de novo synthesis modulate cytosolic and nuclear calcium in human vascular smooth muscle cells. Can J Physiol Pharmacol2003; 81: 274-287.
24.
Jacques D., Abdel Malak NA, Sader S. and Perreault C.Angiotensin II and its receptors in human endocardial endothelial cells: role in modulating intracellular calcium. Can J Physiol Pharmacol2003; 81: 259-266.
25.
Fu ML, Schulze W., Wallukat G., et al. Immunohistochemical localization of angiotensin II receptors (AT1) in the heart with anti-peptide antibodies showing a positive chronotropic effect. Receptors Channels1998; 6: 99-111.
26.
Booz GW, Conrad KM, Hess AL, Singer HA and Baker KMAngiotensin-II-binding sites on hepatocyte nuclei. Endocrinology1992; 130: 3641-3649.
27.
Licea H., Walters MR and Navar LGRenal nuclear angiotensin II receptors in normal and hypertensive rats. Acta Physiol Hung2002; 89: 427-438.
28.
Cook JL, Re R., Alam J., Hart M. and Zhang Z.Intracellular angiotensin II fusion protein alters AT1 receptor fusion protein distribution and activates CREB. J Mol Cell Cardiol2004; 36: 75-90.
29.
den Hartigh JC, van Bergen en Henegouwen PM, Verkleij AJ and Boonstra J.The EGF receptor is an actin-binding protein. J Cell Biol1992 ; 119: 349-355.
30.
van Bergen en Henegouwen PM, den Hartigh JC, Romeyn P., Verkleij AJ and Boonstra J.The epidermal growth factor receptor is associated with actin filaments. Exp Cell Res1992; 199: 90-97.
31.
Friedl P. and Wolf K.Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer2003; 3: 362-374.
32.
Ushio-Fukai M. and Alexander RWCaveolin-dependent angiotensin II type 1 receptor signaling in vascular smooth muscle. Hypertension2006; 48: 797-803.
33.
Fernstrom K. , Farmer P. and Ali MSCytoskeletal remodeling in vascular smooth muscle cells in response to angiotensin II-induced activation of the SHP-2 tyrosine phosphatase. J Cell Physiol2005; 205: 402-413.
34.
Wesselman JP and De Mey JGAngiotensin and cytoskeletal proteins: role in vascular remodeling. Curr Hypertens Rep2002; 4: 63-70.
35.
Montiel M., de la Blanca EP and Jiménez E.Angiotensin II induces focal adhesion kinase/paxillin phosphorylation and cell migration in human umbilical vein endothelial cells. Biochem Biophys Res Commun2005; 327: 971-978.
36.
Nadal JA, Scicli GM, Carbini LA and Scicli AGAngiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB. Am J Physiol Heart Circ Physiol2002; 282: H739-H748.
37.
Saito S., Frank GD, Motley ED, et al. Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation. Biochem Biophys Res Commun2002; 294: 1023-1029.
38.
Kook SH, Lee HJ, Chung WT, et al. Cyclic mechanical stretch stimulates the proliferation of C2C12 myoblasts and inhibits their differentiation via prolonged activation of p38 MAPK. Mol Cells2008; 25: 479-486.
39.
Kumar A., Murphy R., Robinson P., Wei L. and Boriek AMCyclic mechanical strain inhibits skeletal myogenesis through activation of focal adhesion kinase, Rac-1 GTPase, and NFkappaB transcription factor. FASEB J2004; 18: 1524-1535.
40.
Lopez-Ilasaca M., Liu X., Tamura K. and Dzau VJThe angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling. Mol Biol Cell2003; 14: 5038-5050.
41.
Ishii K., Takekoshi K., Shibuya S., Kawakami Y., Isobe K. and Nakai T.Angiotensin subtype-2 receptor (AT2 ) negatively regulates subtype-1 receptor (AT1 ) in signal transduction pathways in cultured porcine adrenal medullary chromaffin cells. J Hypertens2001; 19: 1991-1999.
42.
Inagami T. and Eguchi S.Angiotensin II-mediated vascular smooth muscle cell growth signaling. Braz J Med Biol Res2000; 33: 619-624.
43.
Touyz RM, Deng LY, He G., Wu XH and Schiffrin ELAngiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases . J Hypertens1999; 17: 907-916.
44.
Lijnen P. and Petrov V.Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes . J Mol Cell Cardiol1999; 31: 949-970.
45.
Sundgren NC , Giraud GD, Stork PJ, Maylie JG and Thornburg KLAngiotensin II stimulates hyperplasia but not hypertrophy in immature ovine cardiomyocytes. J Physiol2003; 548: 881-891.
46.
Russell ST, Sanders PM and Tisdale MJAngiotensin II directly inhibits protein synthesis in murine myotubes. Cancer Lett2006; 231: 290-294.
47.
Sanders PM, Russell ST and Tisdale MJAngiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia. Br J Cancer2005; 93: 425-434.
